Clinical trials that rely on subjective or semi-subjective endpoints, such as clinician-reported outcomes or patient-reported symptoms, face distinct challenges when it comes to data integrity.
Variability in interpretation, inconsistent scoring and gaps in training can all compromise outcomes, particularly in international or multicentre studies.
This article highlights some lessons learned in the dermatology field, which relies heavily on subjective outcomes, and outlines strategies for improving data integrity.
Check out the rest of the feature here
